ZEB1 shapes AML immunological niches suppressing CD8 T-cell activity while fostering Th17 cell expansion.
B. Bassani, G. Simonetti, V. Cancila…·S. Sangaletti
This study shows ZEB1 in AML suppresses CD8 T-cells and promotes Th17 cells, contributing to immune suppression and tumor progression.